Normal range of CD4 cell counts and temporal changes in two HIV-negative Malawian populations

Open AIDS Journal

Volumn 5, Issue 1, 2011, Pages 74-79

  Crampin, A C ^a   Mwaungulu, F D ^a   Ambrose, L R ^a   Longwe, H ^a   French, N ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

CD4 count; HIV negative; Malawi; Reference range

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALAWI; MALE; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; RURAL POPULATION; TUBERCULOSIS; URBAN POPULATION;

EID: 80053462891     PISSN: None     EISSN: 18746136     Source Type: Journal    
DOI: 10.2174/1874613601105010074     Document Type: Article

References (32)

1. Tsegaye A, Messele T, Tilahun T, et al. Immunohematological reference ranges for adult Ethiopians. Clin Diagn Lab Immunol 1999; 6(3): 410-4.
2. Williams BG, Korenromp EL, Gouws E, Schmid GP, Auvert B, Dye C. HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. J Infect Dis 2006; 194(10): 1450-8.
3. Menard D, Mandeng MJ, Tothy MB, Kelembho EK, Gresenguet G, Talarmin A. Immunohematological reference ranges for adults from the Central African Republic. Clin Diagn Lab Immunol 2003; 10(3): 443-5.
4. Bussmann H, Wester CW, Masupu KV, et al. Low CD4+ Tlymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin Diagn Lab Immunol 2004; 11(5): 930-5.
5. Ricard D, Wilkins A, N'Gum PT, et al. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 1994; 8(7): 977-82.
6. Levin A, Brubaker G, Shao JS, et al. Determination of Tlymphocyte subsets on site in rural Tanzania: results in HIV-1 infected and non-infected individuals. Int J STD AIDS 1996; 7(4): 288-91.
7. Tugume SB, Piwowar EM, Lutalo T, et al. Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol 1995; 2(2): 233-5.
8. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 29, 2008; 1-128. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf [Accessed 01/05/2008 (p12)].
9. British HIV Association guidelines for treatment of HIV-infected adults with antiretroviral therapy. 2008. http://www.bhiva.org/files/file1030835.pdf [Accessed 01/05/2008 (p11)].
10. Josephson F, Albert J, Flamholc L, et al. Antiretroviral treatment of HIV infection: Swedish recommendations 2007. Scand J Infect Dis 2007; 39(6-7): 486-507.
11. Gallant JE. Should antiretroviral therapy be started earlier? Curr HIV/AIDS Rep 2007; 4(2): 53-9.
12. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2006 revision, http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf [Accessed 01/05/2008 (p14)].
13. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS 2003; 17(5): 711-20.
14. Ahdieh-Grant L, Yamashita TE, Phair JP, et al. When to initiate highly active antiretroviral therapy: a cohort approach. Am J Epidemiol 2003; 157(8): 738-46.
15. (WHO) WHO. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance: African region. Geneva 2005.
16. Anzala AO, Simonsen JN, Kimani J, et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J Infect Dis 2000; 182(2): 459-66.
17. Chirenda J. Low CD4 count in HIV negative malaria cases and normal CD4 count in HIV positive and malaria negative patients. Cent Afr J Med 1999; 45(9): 248.
18. Mboto CI, Davies-Russell A, Fielder M, Jewell AP. CD4+ lymphocyte values and trends in individuals infected with Human Immunodeficiency Virus and/or co-infected with Hepatitis C Virus in The Gambia. Afr Health Sci 2009; 9(3): 130-6.
19. Urassa W, Bakari M, Sandstrom E, et al. Rate of decline of absolute number and percentage of CD4 lymphocytes among HIV-1 infected adults in Dar es Salaam, Tanzania. AIDS 2004; 18(3): 433-8.
20. Raboud JM, Haley L, Montaner JS, Murphy C, Januszewska M, Schechter MT. Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10(Suppl 2): S67-73.
21. Taylor JM, Tan SJ, Detels R, Giorgi JV. Applications of a computer simulation model of the natural history of CD4 T-cell number in HIV-infected individuals. AIDS 1991; 5(2): 159-67.
22. McGrath N, Kranzer K, Saul J, et al. Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS 2007; 21(Suppl 6): S105-13.
23. Sax PE, Boswell SL, White-Guthro M, Hirsch MS. Potential clinical implications of interlaboratory variability in CD4+ Tlymphocyte counts of patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 21(5): 1121-5.
24. Mandigo K, Raboud JM, Haley L, Montaner JS. Variability in leukocyte subset measurements among five laboratories in Vancouver. Clin Invest Med 1995; 18(5): 349-56.
25. Fei DT, Paxton H, Chen AB. Difficulties in precise quantitation of CD4+ T lymphocytes for clinical trials: a review. Biologicals 1993; 21(3): 221-31.
26. MacLennan CA, Liu MK, White SA, et al. Diagnostic accuracy and clinical utility of a simplified low cost method of counting CD4 cells with flow cytometry in Malawi: diagnostic accuracy study. BMJ 2007; 335(7612): 190.
27. Dieye TN, Vereecken C, Diallo AA, et al. Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments. J Acquir Immune Defic Syndr 2005; 39(1): 32-7.
28. Turett GS, Telzak EE. Normalization of CD4+ T-lymphocyte depletion in patients without HIV infection treated for tuberculosis. Chest 1994; 105(5): 1335-7.
29. Prins M, Robertson JR, Brettle RP, et al. Do gender differences in CD4 cell counts matter? AIDS 1999; 13(17): 2361-4.
30. Lugada ES, Mermin J, Kaharuza F, et al. Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol 2004; 11(1): 29-34.
31. Malone JL, Simms TE, Gray GC, Wagner KF, Burge JR, Burke DS. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr 1990; 3(2): 144-51.
32. Badri M, Bekker LG, Orrell C, Pitt J, Cilliers F, Wood R. Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines. AIDS 2004; 18(8): 1159-68.